The 2024 National Foundation for Cancer Research (NFCR) Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted with the AIM-HI Accelerator Fund, convened the world's top experts across cancer research, biotech entrepreneurship, pharmaceuticals, investment, and patient advocacy.
National Foundation for Cancer ResearchOct 28 2024 The 2024 National Foundation for Cancer Research Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted with the AIM-HI Accelerator Fund, convened the world's top experts across cancer research, biotech entrepreneurship, pharmaceuticals, investment, and patient advocacy.
Keynotes on cancer breakthroughs The event began with a keynote address from Drew Pardoll, M.D., Ph.D. , who discussed the transformative impact of checkpoint inhibitors on cancer immunotherapies. Dr. Pardoll addressed the urgent need for biomarkers to predict patient responses, improved clinical trials, and emphasized the need for better combination therapies to make immunotherapy more effective for a broader range of cancer patients.
Shaping the future of cancer care: Panel on early detection and cancer prevention Carlos Doti, M.D. of AstraZeneca, moderated this panel of key leaders to explore current unmet needs, emerging technologies, clinical and policy challenges of implementing cancer screening, and potential strategies that could significantly improve patient outcomes:
Panel on investor perspectives on innovative oncology companies An engaging investor panel, featured insights from leading biotech investors, including Dave Greenwald, Ph.D. , Beverly Lu, Ph.D. , Marie-Claire Peakman, Ph.D. , and Fei Shen, Ph.D. , who discussed the strategic importance of investing in high-risk, high-reward oncology startups.
The future of cancer research panel The evening culminated with a panel discussion emceed by award-winning journalist Kristen Berset-Harris, WUSA9 Great Day Washington, featuring Dennis Slamon, M.D., Ph.D., Margaret Foti, Ph.D., M.D. , Siddhartha Mukherjee, M.D., Olufunmilayo Olopade, M.D., Mohit Manrao, MBA, and patient advocates, Shereen and Isabella Pavlides, NFCR Ambassadors.
Antibody Artificial Intelligence Breast Cancer Cancer Diagnostics Cancer Prevention Cancer Treatment Cell Diagnostics DNA Drugs Gene Healthcare Immunotherapy Medical School Medicine Oncology Ph Pharmaceuticals Research Therapeutics
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cancer Research UK backs study to develop preventive ovarian cancer vaccineIn this study, the Cancer Research UK-funded scientists will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most strongly recognized by the immune system and how effectively the vaccine kills mini-models of ovarian cancer called organoids.
Read more »
Innovative nanoparticle therapy offers hope in fighting prostate cancerProstate cancer is the second leading cause of cancer death among American men.
Read more »
FDA-approved breast cancer drug shows promise for appendix cancerResearchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer has the potential to be an effective therapeutic for a specific type of appendix cancer.
Read more »
HER2-postive breast cancer drugs show promise for bile duct cancer treatmentDrugs designed to target HER2-postive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial to be presented on Thursday at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.
Read more »
Ludlow Cancer Support Group donates £450 to Breast Cancer NowIn honour of Breast Cancer Awareness Month, Ludlow Cancer Support Group (LCSG) members donned their finest pink attire on Friday, October 11th, to raise awareness and funds for Breast Cancer Now.
Read more »
Cutting off cancer cells' access to fats may enhance cancer therapyCutting off cancer cells' access to fat may help a specific type of cancer treatment work more effectively, reports a study by Van Andel Institute scientists.
Read more »